PainChek Ltd
ASX:PCK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
PainChek Ltd
Net Income (Common)
PainChek Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
PainChek Ltd
ASX:PCK
|
Net Income (Common)
-AU$9.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-18%
|
|
|
4DMedical Ltd
ASX:4DX
|
Net Income (Common)
-AU$165m
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Net Income (Common)
$10.8m
|
CAGR 3-Years
46%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
|
|
Pro Medicus Ltd
ASX:PME
|
Net Income (Common)
AU$234.7m
|
CAGR 3-Years
66%
|
CAGR 5-Years
57%
|
CAGR 10-Years
48%
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Net Income (Common)
AU$3.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Net Income (Common)
-AU$16.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-65%
|
CAGR 10-Years
N/A
|
|
PainChek Ltd
Glance View
PainChek Ltd. engages in the development and commercialisation of mobile medical device applications. The company is headquartered in Sydney, New South Wales. The company went IPO on 2012-05-01. The Company’s principal activities are development and commercialization of mobile medical device applications, that automate intelligent pain assessment of individuals who are unable to communicate their pain with carers. Its Paincheck is an Adult and Infant pain assessment applications. Its PainChek technology uses cameras in smartphones and tablets to capture a brief video of the person, which is analyzed in real time using facial recognition software to detect the presence of facial micro-expressions that are indicative of the presence of pain. Its Paincheck uses artificial intelligence (AI) to automatically assess the micro-facial features of pain. Its PainChek technology has multiple regulatory clearances, including TGA (Australia) and CE Mark (Europe) for use as a class 1 medical device to assess pain in people who are unable to reliably verbalize, such people with dementia.
See Also
What is PainChek Ltd's Net Income (Common)?
Net Income (Common)
-9.2m
AUD
Based on the financial report for Dec 31, 2025, PainChek Ltd's Net Income (Common) amounts to -9.2m AUD.
What is PainChek Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-18%
Over the last year, the Net Income (Common) growth was -13%. The average annual Net Income (Common) growth rates for PainChek Ltd have been -10% over the past three years , -19% over the past five years , and -18% over the past ten years .
